Ornidazole

- Aug 28, 2018 -

For the treatment of Bacteroides fragilis, Bacteroides diarrhii, Bacteroides gracilis, Bacteroides variabilis, Bacteroides genus, Clostridium, bacillus, Peptococcus and Streptococcus pneumoniae, Helicobacter pylori, Bacteroides melanogaster, A variety of infectious diseases caused by susceptible anaerobic bacteria such as Fusobacterium, CO2 phagocytic bacteria, and gingival bacillus


Indication

1. For the treatment of Bacteroides fragilis, Bacteroides diarrhii, Bacteroides gracilis, Bacteroides variabilis, Bacteroides genus, Clostridium, bacillus, Peptococcus and Streptococcus pneumoniae, Helicobacter pylori, Bacteroides melanogaster, A variety of infectious diseases caused by susceptible anaerobic bacteria such as Fusobacterium, CO2 phagocytic bacteria, and gingival bacilli, including:

1) abdominal infection: cell membrane inflammation, intra-abdominal abscess, liver abscess, etc.;

2) pelvic infection: endometritis, uterine myositis, fallopian tube or ovarian abscess, pelvic soft tissue infection, Haemophilus vaginitis, etc.;

3) Oral infections: periodontitis, periapical inflammation, pericoronitis, acute ulcerative gingivitis, etc.;

4) Surgical infection: wound infection, epidermal abscess, hemorrhoid ulcer infection, cellulitis, gas gangrene, etc.;

5) Brain infection: meningitis, brain abscess;

6) Severe anaerobic infections such as sepsis and bacteremia.


2. For the treatment of infection before surgery and anaerobic infection after surgery.


3. Treatment of severe amoebiasis in the digestive system, such as amoebic dysentery, amoebic liver abscess, etc.